An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
Clinical trial NCT02969265 · WITHDRAWN
Trial details
- NCT number
- NCT02969265
- Sponsor
- Takeda
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2018-07-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.